Every trade that managers of MPX Bioceutical Corporation disclose to SEDI is tracked on this page. MPX Bioceutical Corporation has had no insider filing for more than a year; the last one goes back to 9 January 2019.
Our records for MPX Bioceutical Corporation go back to 2017, with 1 purchase and 16 sales on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 28 declarations
MPX Bioceutical Corporation is a company focused on health products related to cannabis. It is listed on the Toronto Stock Exchange under the symbol XTSE.